{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:14:36Z","timestamp":1779261276053,"version":"3.51.4"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["U2CCA252971"],"award-info":[{"award-number":["U2CCA252971"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.amjsurg.2026.116941","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:48:01Z","timestamp":1774486081000},"page":"116941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Uncovering molecular pathways in appendiceal cancer: A comprehensive characterization for precision oncology"],"prefix":"10.1016","volume":"257","author":[{"given":"Thinzar Min","family":"Lwin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigette","family":"Waldrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco G.","family":"Carranza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Manjarrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gagandeep","family":"Brar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rifat","family":"Mannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Raoof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3603-6414","authenticated-orcid":false,"given":"Enrique","family":"Velazquez-Villarreal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.amjsurg.2026.116941_bib1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1634\/theoncologist.2017-0081","article-title":"Appendiceal mucinous neoplasms: diagnosis and management","volume":"22","author":"Shaib","year":"2017","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.116941_bib2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/jso.25641","article-title":"Appendiceal cancer masked as inflammatory appendicitis in the elderly, not an uncommon presentation (Surveillance Epidemiology and End Results (SEER)-medicare analysis)","volume":"120","author":"Siddharthan","year":"2019","journal-title":"J Surg Oncol"},{"issue":"11","key":"10.1016\/j.amjsurg.2026.116941_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294153","article-title":"Incidence trends and survival analysis of appendiceal tumors in the United States: primarily changes in appendiceal neuroendocrine tumors","volume":"18","author":"Wang","year":"2023","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.116941_bib4","first-page":"441","article-title":"Appendiceal cancer : a review of the literature","volume":"83","author":"Van de Moortele","year":"2020","journal-title":"Acta Gastroenterol Belg"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.116941_bib5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/his.13324","article-title":"The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei","volume":"71","author":"Carr","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.amjsurg.2026.116941_bib6","first-page":"1","article-title":"Current management of appendiceal neoplasms","volume":"41","author":"Hoehn","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.116941_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.116941_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cncr.29744","article-title":"The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: analysis of the national cancer data base","volume":"122","author":"Asare","year":"2016","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.116941_bib9","first-page":"590","article-title":"American joint committee on cancer expert panel on cancers for the lower gastrointestinal appendix disease site. Survival outcomes used to validate version 9 of the American joint committee on cancer staging system for appendiceal cancer","volume":"73","author":"Janczewski","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.amjsurg.2026.116941_bib10","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.22.01392","article-title":"Molecular classification of appendiceal adenocarcinoma","volume":"41","author":"Foote","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116941_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.amjsurg.2026.116941_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2022.104787","article-title":"The PI3K\/AKT signaling pathway in cancer: molecular mechanisms and possible therapeutic interventions","volume":"127","author":"Khezri","year":"2022","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116941_bib13","first-page":"104","article-title":"Portrait of the PI3K\/AKT pathway in colorectal cancer","volume":"1855","author":"Danielsen","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.116941_bib14","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3390\/ijms25031848","article-title":"Targeting PI3K\/AKT\/mTOR and MAPK signaling pathways in gastric cancer","volume":"25","author":"Morgos","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.amjsurg.2026.116941_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103749","article-title":"Prospects of targeting PI3K\/AKT\/mTOR pathway in pancreatic cancer","volume":"176","author":"Mortazavi","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.116941_bib16","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/ijms24032652","article-title":"The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism","volume":"24","author":"Tian","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.amjsurg.2026.116941_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.116941_bib18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/07853890.2014.912836","article-title":"PI3K\/AKT signaling pathway and cancer: an updated review","volume":"46","author":"Martini","year":"2014","journal-title":"Ann Med"},{"issue":"14","key":"10.1016\/j.amjsurg.2026.116941_bib19","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.3390\/cancers15143591","article-title":"Landscape of genetic mutations in appendiceal cancers","volume":"15","author":"Constantin","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116941_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188556","article-title":"Tumor suppressor p53: biology, signaling pathways, and therapeutic targeting","volume":"1876","author":"Hern\u00e1ndez Borrero","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.amjsurg.2026.116941_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107720","article-title":"Current developments of targeting the p53 signaling pathway for cancer treatment","volume":"220","author":"Huang","year":"2021","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116941_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","article-title":"Targeting p53 pathways: mechanisms, structures, and advances in therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.116941_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4291\/wjgp.v14.i3.46","article-title":"Role of p53 suppression in the pathogenesis of hepatocellular carcinoma","volume":"14","author":"Choudhary","year":"2023","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.116941_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ccell.2020.05.010","article-title":"Altered RNA splicing by mutant p53 activates oncogenic RAS signaling in pancreatic cancer","volume":"38","author":"Escobar-Hoyos","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.amjsurg.2026.116941_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104018","article-title":"The prognostic role of p53 mutations in metastatic colorectal cancer: a systematic review and meta-analysis","volume":"186","author":"Ottaiano","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.amjsurg.2026.116941_bib26","article-title":"Genomic landscape of appendiceal neoplasms","volume":"2","author":"Ang","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.amjsurg.2026.116941_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semcancer.2017.11.016","article-title":"Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: its clinical implications","volume":"54","author":"Imperial","year":"2019","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116941_bib28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","article-title":"Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"issue":"11","key":"10.1016\/j.amjsurg.2026.116941_bib29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1080\/14728222.2019.1685501","article-title":"RAS\/RAF\/MEK\/ERK, PI3K\/PTEN\/AKT\/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma","volume":"23","author":"Akula","year":"2019","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.116941_bib30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/gcc.22813","article-title":"The extended spectrum of RAS-MAPK pathway mutations in colorectal cancer","volume":"59","author":"Costigan","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.amjsurg.2026.116941_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.critrevonc.2015.12.005","article-title":"The wnt signaling pathway in cancer","volume":"99","author":"Duchartre","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116941_bib32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","article-title":"Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy","volume":"17","author":"Song","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"11","key":"10.1016\/j.amjsurg.2026.116941_bib33","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/onc.2016.304","article-title":"Wnt signaling in cancer","volume":"36","author":"Zhan","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.amjsurg.2026.116941_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1410513","article-title":"Wnt signaling in gastric cancer: current progress and future prospects","volume":"14","author":"Han","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.amjsurg.2026.116941_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110851","article-title":"WNT\/\u03b2-catenin signaling in the development of liver cancers","volume":"132","author":"He","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.amjsurg.2026.116941_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150348","article-title":"Role of Wnt\/\u03b2-catenin pathway in cancer drug resistance: insights into molecular aspects of major solid tumors","volume":"729","author":"Samant","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.amjsurg.2026.116941_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9390878","article-title":"Role of Wnt\/\u03b2-Catenin signaling in the chemoresistance modulation of colorectal cancer","volume":"2020","author":"Yuan","year":"2020","journal-title":"BioMed Res Int"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116941_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","article-title":"Targeting TGF-\u03b2 signaling in cancer","volume":"3","author":"Colak","year":"2017","journal-title":"Trends Cancer"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.116941_bib39","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/jcb.25496","article-title":"TGF-\u03b2 signaling in cancer","volume":"117","author":"Syed","year":"2016","journal-title":"J Cell Biochem"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.116941_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7150\/ijbs.23230","article-title":"The role of TGF-\u03b2\/SMAD4 signaling in cancer","volume":"14","author":"Zhao","year":"2018","journal-title":"Int J Biol Sci"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.116941_bib41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cels.2018.03.003","article-title":"Pan-cancer alterations of the MYC oncogene and its proximal network across the Cancer genome atlas","volume":"6","author":"Schaub","year":"2018","journal-title":"Cell Syst"},{"issue":"22","key":"10.1016\/j.amjsurg.2026.116941_bib42","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.amjsurg.2026.116941_bib43","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd4281","article-title":"Targeting RAS-ERK signalling in cancer: promises and challenges","volume":"13","author":"Samatar","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116941_bib44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol Mol Biol Rev"},{"issue":"8","key":"10.1016\/j.amjsurg.2026.116941_bib45","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1016\/j.amjsurg.2026.116941_bib46","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of Ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res"},{"issue":"6892","key":"10.1016\/j.amjsurg.2026.116941_bib47","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.116941_bib48","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/cdd.2008.148","article-title":"Tumour cell survival signalling by the ERK1\/2 pathway","volume":"16","author":"Balmanno","year":"2009","journal-title":"Cell Death Differ"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.116941_bib49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.116941_bib50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGFbeta in cancer","volume":"134","author":"Massagu\u00e9","year":"2008","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.amjsurg.2026.116941_bib51","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022053","article-title":"Signaling receptors for TGF-\u03b2 family members","volume":"8","author":"Heldin","year":"2016","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"10","key":"10.1016\/j.amjsurg.2026.116941_bib52","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGF\u03b2 signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.116941_bib53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2853","article-title":"TGFbeta signalling: a complex web in cancer progression","volume":"10","author":"Ikushima","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.116941_bib54","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0002-9440(10)64625-1","article-title":"Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease","volume":"157","author":"Maitra","year":"2000","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.116941_bib55","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth Factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"issue":"7693","key":"10.1016\/j.amjsurg.2026.116941_bib56","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.amjsurg.2026.116941_bib57","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O'Shea","year":"2015","journal-title":"Annu Rev Med"},{"issue":"Pt 8","key":"10.1016\/j.amjsurg.2026.116941_bib58","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","article-title":"The JAK\/STAT signaling pathway","volume":"117","author":"Rawlings","year":"2004","journal-title":"J Cell Sci"},{"issue":"11","key":"10.1016\/j.amjsurg.2026.116941_bib59","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.amjsurg.2026.116941_bib60","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0","article-title":"Activation of STAT proteins and growth control","volume":"23","author":"Bromberg","year":"2001","journal-title":"Bioessays"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116941_bib61","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/mi.11.1.4","article-title":"STAT3 signaling: anticancer strategies and challenges","volume":"11","author":"Johnston","year":"2011","journal-title":"Mol Interv"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.116941_bib62","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.amjsurg.2026.116941_bib63","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","article-title":"The role of IL-6 and STAT3 in inflammation and cancer","volume":"41","author":"Hodge","year":"2005","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.116941_bib64","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1593\/neo.04571","article-title":"Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth","volume":"7","author":"Corvinus","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.amjsurg.2026.116941_bib65","series-title":"Digestive System Tumours","year":"2019"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116941_bib66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process","volume":"40","author":"Carr","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.amjsurg.2026.116941_bib67","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/00000478-200308000-00006","article-title":"Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases","volume":"27","author":"Misdraji","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"13","key":"10.1016\/j.amjsurg.2026.116941_bib68","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1245\/s10434-024-16254-0","article-title":"Reclassification of appendiceal mucinous neoplasms and associated pseudomyxoma peritonei according to the peritoneal surface oncology group international consensus: clinicopathological reflections of a two-center cohort study","volume":"31","author":"Rauwerdink","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.amjsurg.2026.116941_bib69","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0b013e31817f1816","article-title":"Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix","volume":"32","author":"Tang","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.amjsurg.2026.116941_bib70","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/SLA.0b013e318269d680","article-title":"Improving the AJCC\/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade","volume":"257","author":"Overman","year":"2013","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.amjsurg.2026.116941_bib71","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1245\/s10434-007-9557-7","article-title":"Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum","volume":"14","author":"Varghese","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.amjsurg.2026.116941_bib72","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1158\/1078-0432.CCR-24-2474","article-title":"The landscape of ctDNA in appendiceal adenocarcinoma","volume":"31","author":"White","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.amjsurg.2026.116941_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1513821","article-title":"Current state and future prospects of spatial biology in colorectal cancer","volume":"14","author":"Carranza","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.amjsurg.2026.116941_bib74","article-title":"Integrative multi-omics profiling of colorectal cancer from a Hispanic\/Latino cohort of patients","author":"Waldrup","year":"2024","journal-title":"medRxiv"},{"issue":"18","key":"10.1016\/j.amjsurg.2026.116941_bib75","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.3390\/ijms26189067","article-title":"Artificial intelligence-enhanced precision medicine reveals prognostic impact of TGF-beta pathway alterations in FOLFOX-treated early-onset colorectal cancer among disproportionately affected populations","volume":"26","author":"Diaz","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.amjsurg.2026.116941_bib76","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/cancers17081325","article-title":"Molecular heterogeneity in early-onset colorectal cancer: pathway-specific insights in high-risk populations","volume":"17","author":"Monge","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"17","key":"10.1016\/j.amjsurg.2026.116941_bib77","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.3390\/cancers17172833","article-title":"Precision oncology insights into WNT pathway alterations in FOLFOX-treated early-onset colorectal cancer in high-risk populations","volume":"17","author":"Diaz","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.amjsurg.2026.116941_bib78","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3390\/cancers17071075","article-title":"Molecular alterations in TP53, WNT, PI3K, TGF-Beta, and RTK\/RAS pathways in gastric cancer among ethnically heterogeneous cohorts","volume":"17","author":"Monge","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.amjsurg.2026.116941_bib79","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/cancers17081309","article-title":"Comparative genomic analysis of key oncogenic pathways in hepatocellular carcinoma among diverse populations","volume":"17","author":"Monge","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.amjsurg.2026.116941_bib80","doi-asserted-by":"crossref","first-page":"7695","DOI":"10.3390\/ijms26167695","article-title":"Pathway-specific genomic alterations in pancreatic cancer across populations at risk","volume":"26","author":"Monge","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.amjsurg.2026.116941_bib81","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btaf359","article-title":"AI-HOPE: an AI-driven conversational agent for enhanced clinical and genomic data integration in precision medicine research","volume":"41","author":"Yang","year":"2025","journal-title":"Bioinformatics"},{"key":"10.1016\/j.amjsurg.2026.116941_bib82","doi-asserted-by":"crossref","DOI":"10.2196\/76553","article-title":"Conversational artificial intelligence for integrating social determinants, genomics, and clinical data in precision medicine: development and implementation study of the AI-HOPE-PM system","volume":"6","author":"Yang","year":"2025","journal-title":"JMIR Bioinform Biotech"},{"key":"10.1016\/j.amjsurg.2026.116941_bib83","article-title":"Autonomous AI system takes on cancer treatment planning","author":"Dolgin","year":"2025","journal-title":"Cancer Discov"},{"key":"10.1016\/j.amjsurg.2026.116941_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113993","article-title":"Disorders of cancer metabolism: the therapeutic potential of cannabinoids","volume":"157","author":"Sun","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.amjsurg.2026.116941_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.901559","article-title":"Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway","volume":"13","author":"Tong","year":"2022","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.116941_bib86","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14489","article-title":"A TGF-\u03b2 signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response","volume":"30","author":"Duan","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.amjsurg.2026.116941_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118209","article-title":"Revealing the role of bisphenol A on prostate cancer progression and identifying potential targets: a comprehensive analysis from population cohort to molecular mechanism","volume":"296","author":"Zhou","year":"2025","journal-title":"Ecotoxicol Environ Saf"},{"issue":"12","key":"10.1016\/j.amjsurg.2026.116941_bib88","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3390\/pharmaceutics16121582","article-title":"Precisely tailoring molecular structure of doxorubicin prodrugs to enable stable nanoassembly, rapid activation, and potent Antitumor effect","volume":"16","author":"Feng","year":"2024","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.amjsurg.2026.116941_bib89","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.7150\/ijbs.78535","article-title":"The emerging role of super-enhancers as therapeutic targets in the digestive system tumors","volume":"19","author":"Li","year":"2023","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10.1016\/j.amjsurg.2026.116941_bib90","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13062-024-00518-6","article-title":"Disulfidptosis signature predicts immune microenvironment and prognosis of gastric cancer","volume":"19","author":"Liu","year":"2024","journal-title":"Biol Direct"},{"key":"10.1016\/j.amjsurg.2026.116941_bib91","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6782046","article-title":"Gene coexpression network and module analysis across 52 human tissues","volume":"2020","author":"He","year":"2020","journal-title":"BioMed Res Int"},{"issue":"12","key":"10.1016\/j.amjsurg.2026.116941_bib92","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/jvh.13886","article-title":"CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes","volume":"30","author":"Ning","year":"2023","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.amjsurg.2026.116941_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2025.105096","article-title":"Effects of advance care planning for patients with advanced cancer: a meta-analysis of randomized controlled studies","volume":"168","author":"Zhang","year":"2025","journal-title":"Int J Nurs Stud"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961026001248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961026001248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:41:12Z","timestamp":1779259272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961026001248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":93,"alternative-id":["S0002961026001248"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2026.116941","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncovering molecular pathways in appendiceal cancer: A comprehensive characterization for precision oncology","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2026.116941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116941"}}